Evidence map›Paper›PMID 27698758›Full record

ArticleExperimental and therapeutic medicine2016

Mucosa-reparing and microbiota-balancing therapeutic effect of

Hui-Lu Zhang, Wen-Shuai Li, Dian-Nan Xu, Wan-Wei Zheng, Yi Liu, Jian Chen, Zhi-Bing Qiu, Robert G Dorfman, Jun Zhang, Jie Liu

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Conversations in the Gut: The Role of Quorum Sensing in Normobiosis.International journal of molecular sciences · 2023
    Review
  7. Autoclaved Diet with Inactivated Spores ofAnimals : an open access journal from MDPI · 2022
    Article
  8. Nutrients · 2022
    Article
  9. Review
  10. Article
  11. Review
  12. The Use ofAnimals : an open access journal from MDPI · 2021
    Article
  13. Neuroimmunomodulation by gut bacteria: Focus on inflammatory bowel diseases.World journal of gastrointestinal pathophysiology · 2021
    Review
  14. Journal of microbiology and biotechnology · 2021
    Article
  15. Protective Role of a New Polysaccharide Extracted fromBioMed research international · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Hui-Lu ZhangDepartment of Digestive Diseases, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
Wen-Shuai LiDepartment of Digestive Diseases, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
Dian-Nan XuDepartment of Immunology, Institute of Biomedical Sciences, Fudan University, Shanghai 200032, P.R. China.
Wan-Wei ZhengDepartment of Digestive Diseases, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
Yi LiuDepartment of Digestive Diseases, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
Jian ChenDepartment of Digestive Diseases, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
Zhi-Bing QiuDepartment of Digestive Diseases, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
Robert G DorfmanMD Candidate, Class of 2018, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Jun ZhangDepartment of Digestive Diseases, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
Jie LiuDepartment of Digestive Diseases, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China; Department of Immunology, Institute of Biomedical Sciences, Fudan University, Shanghai 200032, P.R. China.
Fudan University · CNHuashan Hospital · CNNorthwestern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gut microbiota composition of patients with ulcerative colitis (UC) is markedly altered compared with healthy individuals. There is mounting evidence that probiotic therapy alleviates disease severity in animal models and patients with inflammatory bowel disease (IBD).

Indexed as

Bacillus subtilismouseulcerative colitis

Identifiers

PMID27698758
PMCPMC5038491
OpenAlexW2516553869

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.